Central Lines Infection Paper

Catheter related bloodstream infections are not only responsible for prolonged hospital stays and increased hospital costs, it is also responsible for increased mortality of the hospitalized patients. According to Centers for Disease Control and Prevention (2017), an estimate of 30,100 central line-associated bloodstream infections (CLABSI) occur in intensive care units and wards of U.S. acute care facilities each year. CLABSI is a serious hospital-acquired infection that occurs when bacteria enters the bloodstream through central venous catheters. CLABSI is preventable as long as health-care personnel practice aseptic techniques when working with the catheter. A blood culture swabbed from the tip of the catheter is needed to confirm the

Getting an infection from improper care during or after insertion of a central line is the last thing you want to get while in the hospital. This paper will discuss Kaiser Permanente’s policy on central venous catheter, also known as a central line, care and dressing change, and whether it follows the current evidence-based practice on preventing bloodstream infection in patients who have them inserted. I will explain about what a central line is, why evidence-based practice is important in the clinical setting, what Kaiser Permanente’s policy about central line care and dressing change is, if Kaiser is currently following evidence-based practice based on current articles about preventing central line associated bloodstream infections (CLABSIs), and what my role in using evidence-based practice is as a future registered nurse.

Article by Clancy (2009) explained central lines were a result of an estimated 250,000 blood stream infections and accounted for 30,000 to 62,000 patient deaths, then adding that each infection cost upwards of $36,000 and cumulatively add up to at least $9 billion in preventable costs annually. The article also explains how the mindset has changed from the cost of having a central line in place and expecting complications to lowering infection rates by an intentional interventional process/s. The article speaks of 5 basic steps to reduce CLABSI, hand washing, insertion techniques, skin cleansing, avoidance of certain sites and earlier removal of the CVC. Studies showed that these guidelines were only followed 62% of the time. The system was changed to ascertain that all the clinicians were in compliance. This prompted 5 interventions, education, a CVC insertion cart with all necessary equipment, physicians having to validate central line necessity, a concise checklist for bedside clinicians and the empower of nurses to stop procedures if guidelines were not followed. These low cost interventions from 11.3/1000 in catheter days in 1998 to zero in the fourth quarter of 2002.

The purpose of this initiative is to decrease and/or eliminate central line-associated bloodstream infections (CLABSI) in the neonatal intensive care unit (NICU) at Aurora Bay Care Medical Center. Hospital acquired infections, including CLABSI, is a major cause of mortality, prolonged hospitalization, and extra costs for NICU patients (Stevens & Schulman, 2012). The goal of this initiative is to decrease CLABSI by 75% by reducing the number of days lines are in and standardizing the insertion process and line maintenance.

The use of disinfecting Curos™ caps must be a routine practice on all oncology floors. This change can readily be implemented, as it does not take much training to learn how to use. The Curos™ caps should also be implemented already existing CLABSI prevention bundles. Considering the 12-25% high mortality rates of CLABSI, implementing the disinfecting caps could reduce the rates of CLABSI by as much as 66% (Whitfield& Lowe, 2013). According to Ramirez, Lee, & and Welch(2014) “ During 2010,the CLABSI rate reduced from 1.9 to 0.5 per 1,000 catheter days during a one-year trial period. Furthermore, compliance to CLABSI prevention bundles increased from 63% to 80% when implementing the disinfecting Curos ™ caps. This high

Healthcare-associated infections from invasive medical devices are linked to high morbidity, mortality, and costs worldwide. Especially in central line–associated bloodstream infection (CLABSI) or catheter-related bloodstream infection (CRBSI) and

Central line bundle is a group of evidence-based practice strategy for patient with central catheters, when implemented together, produce better outcomes than implemented individually (Institute of health care improvement, 2010.). The main elements of central line bundle are hand hygiene, maximal barrier precaution upon insertion, Chlorhexidine skin antisepsis, optimal catheter selection, and daily review of line necessity with prompt removal of unnecessary lines Aseptic technique when using and caring for a central line catheter can decrease the chance of contamination in this critically ill infants. Staff education on adherence to aseptic technique and strict central line care guidelines are essential to decreasing bloodstream infections.

As the CEO of a hospital with the highest Central-Line Associated Blood Stream Infections (CLABSI), I am approaching the problem from an evidence-based standpoint. My first step is to engage each team member, especially senior leadership, and ensure that everyone is on board to reduce CLABSI occurrences. In a formal, mandatory meeting, I am giving all staff members a detailed overview of the plan as well as an achievable goal for the upcoming fiscal year. While outlining my expectations, I will welcome the infection control team to discuss successful evidence-based strategies and practices.

Hospital acquired infections (HAI) are inflecting a tremendous impact on healthcare safety and medical costs. The purpose of this qualitative analysis is to evaluate current research and evidence based practice on central line acquired blood stream infections (CLABSI) in the neonatal intensive care unit (NICU). Further, this paper will examine how the closed medication line system can help decrease of a CLABSI event. Neonates are a vulnerable population with a low immune suppression where an infection could simply mean life or death. This particular topic is crucial; with the continual rise in pre-term neonates, this topic is crucial to eliminate CLABSI 100% in the NICU environment

Lastly, non-adherence to Aseptic techniques for surgical patients and with the use invasive of devices such as urinary catheter and central lines can pose as a threat to patients. Bathing patients prior to surgery with a chlorhexidine solution rather than regular soap has proven to reduce the spread of hospital acquired infections. Following protocols with urinary catheters and central lines and also following the guidelines in the care and maintenance of such devices. Another factor is the importance of using chlorhexidine solution for patients who have central lines in an effort to prevent getting an infection in the blood stream. Finally, the importance educating patients on all lines and surgical site care. According to Lobley, “the National Institute for Health and Clinical Excellence found that surgical site infections (SSIs) accounted for 14% of all HAIs and affected 5% of all surgical patients” (Lobley, 2013). Surgical site infection which is another form of hospital acquired infection can

The CDC’s National Healthcare Safety Network (NHSN) supports 2,000 hospitals nationally (Central line-associated bloodstream infections, n.d.). Since March 2010, hospitals, in twenty one of the United States’ fifty states, are required to report their hospital acquired infections to the NHSN (Central line-associated bloodstream infections, n.d.). The CMS data report includes identification numbers for the hospitals the CLABSI happened at, the name and address of the hospitals, the number days the central line was in, the number of CLABSI incidences the hospitals had, and each hospitals’ National Healthcare Safety Network standardized infection ratio (SIR) (Tabak et al.,

When people go into hospitals, they expect to be treated from what illness they have. The US Center for Disease Control and Prevention states that one in twenty-five patients will obtain nosocomial infections (Mercola No p). Readers may think that these statistics are not that bad, but when readers become educated on how dangerous and how easy it is to acquire this infection they will think twice. The most common ways to acquire nosocomial infections are central line-associated bloodstream, catheter-associated urinary tract, surgical site after surgery, clostridium difficile infections (Mercola No. p). People may think to take antibiotics to help get over illness. In the long run taking antibiotics is not always going to help a person. Some pathogens that antibiotics are resistant to are Carbapenem-resistant Enterobacteriaceae (CRE), Neisseria Gonorrhoeae,

It is estimated that 200,000 to 400,000 hospitalized patients with central lines develop bloodstream infections annually in the United States. The prevalence of central line-associated blood stream infections (CLABSIs) have increased, and significantly caused morbidity and mortality in patients. They are a leading cause of preventable health care-associated infections (HAIs) and have resulted in longer hospital stays and higher hospital costs. In order to combat this epidemic, the Centers for Disease Control and Prevention (CDC) aimed at the prevention and reduction of CLABSIs with the development of what is known as the CLABSI Bundle. Efforts by the CDC were paramount in reducing the rate of CLABSI and improving the quality of care

Infections are a significant problem in many medical and environmental situations. These infections are caused by an array of different microorganisms including bacteria, protozoa, fungi, yeasts, and viruses. The prevention of infections, and reduction or elimination of an infection once it is established is of importance,6 particularly in the area of skin and wound care. Environments that increase a patient's risk to infection include the surfaces of objects (internally and externally), fluids and fluid conduits. In healthcare, infections lead to longer hospital stays for patients and increased hospital costs. Even worse, a large number of patient deaths are attributed to infections.

Blood-stream infections affect more than 700,000 in the U.S. resulting in a healthcare cost of $20 billion annually. The current standard is to administer multiple general antibiotics first, followed by a blood culture to identify the infecting bacteria. This method takes days and puts the patient at risk because these general antibiotics are not often effective due to the rise of antibiotic-resistant bacteria. Doctors overmedicate hospital patients due to the wait time for infection analysis. This excessive medication has led to the deaths of patients. Instead of doing lab analysis, the rapid diagnostic device receive the blood sample, analyze whether the type of infection, and report the effective medications. This would prevent the prescription